IGFBP3 and cancer: IGFBP-3 has been reported to be a binding partner of retinoic receptors (RXR and RAR), where these receptors are essential for IGFBP-3-induced apoptosis in cancer cell lines, and for the inhibitory effect of IGFBP-3 on preadipocyte maturation [74].